San Francisco, CA, June 24, 2021 – Volansi has been recognized as an Airwards winner for its partnership with Merck & Co., known as MSD outside the United States and Canada, and commitment to improving commercial deliveries of temperature-controlled vaccines in rural North Carolina.

Volansi is the leader in Vertical Takeoff and Landing (VTOL) enabled commercial delivery services. Leveraging autonomous drone technology, Volansi is revolutionizing supply chains and delivering critical parts, essential supplies and life-saving medicines where it could otherwise face unpredictable delays.

This is the case in rural North Carolina where Volansi has partnered with Merck to deliver temperature-controlled vaccines to Vidant Healthplex-Wilson, a Vidant Health clinic. With 1.4 million people across 29 counties, eastern North Carolina’s vast, rural environment creates challenges for accessing healthcare and essential medicines. Temperature-sensitive vaccines present a unique problem due to the required temperature range that they must be stored in during transit. Exposure to temperatures outside of a vaccine’s designated range can result in reduced potency and other adverse effects. The VOLY 10 Series’ ability to operate without the limitations of infrastructure shortens the amount of time these vaccines and medications spend in transit and ensures they reach their destination within their designated temperature range.

In September 2020, Volansi completed its first successful delivery operation of measles, mumps and rubella vaccine doses for Merck – the first ever drone delivery of temperature-controlled vaccines within the U.S. This operation was the first part of a three-phase project to explore innovative delivery options to complement existing supply chain capabilities with the next phases aimed at expanding delivery operations in other remote locations.

All of this led to Airwards recognizing Volansi with the top award in the organization’s Operations – Delivery category for 2021. Airwards is the first awards platform of its kind to identify, recognize and champion groundbreaking, impactful and positive drone use cases globally.

“Volansi and Merck are addressing a critical need to provide better access to vaccines in rural North Carolina. By developing innovative ways to transport vaccines that require storage between 2-8°C, we have enabled on-demand, just-in-time delivery to healthcare providers when they need these supplies most,” said Hannan Parvizian, Volansi CEO and Co-founder.

A total of 26 Airwards judges contributed to creating the inaugural list of winners for 2021. Judges included industry experts from leading autonomous systems organizations and research institutions from around the world.

Airwards were presented in six categories – Technology, Operations, Support Services, Industry/Field, Giving Back and People’s Choice. Each category included several sub-categories, including Delivery, Airspace Management, Sensors and Payloads, Training and Certification, Public Safety and more.

“This mature operation uses drones to help people at times of great need,” Airwards judges said of Volansi’s cold-chain medication and vaccine delivery services. “The project is founded upon responsibility and safety and has demonstrated its use in multiple practice and regulatory environments. This innovative application shows how a multitude of existing technologies can be brought together to create a novel service that pushed the boundaries of existing regulations and operations.”

About Volansi
Volansi provides fast, on-demand, point-to-point aerial delivery services for time-critical shipments over long ranges. We build and operate long-range, heavy-payload drones for commercial, defense and humanitarian applications. Leveraging drone technology as a transportation method, we help our customers gain control of their supply chain by delivering critical equipment and aid where it otherwise faces unpredictable delays-helping to save time, money and lives. To learn more, visit volansi.com or follow us on Twitter @Volans_i.